1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
  1. My Preqin
Book a demo

Nexus Oncology Ltd.

Have updates for this profile?  Please contribute data

About Financials Deals
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

1999

Location

Edinburgh UK

Primary Industry

Pharmaceuticals

About

Founded in 1999 and based in Edinburgh, United Kingdom, Nexus Oncology Ltd. engages in the design and implementation of drug development programs across phase I, II, and III oncology trials for the international biopharmaceutical industry.
Current Investors
Ockham Development Group Inc.

Request a demo to show more

Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.nexusoncology.com
Company Stage
Add-on
Total Amount Raised
Subscriber access only

Financials

Fiscal Year Ended
Revenue (USD)
% Revenue Growth (YoY)
Operating Income (USD)
Operating Margin
EBITDA (USD)
% EBITDA Margin
NET Income (USD)
% Net Margin
30 Apr 2009
7,165,220
-
(95,852)
(1.3%)
(49,996)
(0.7%)
(56,073)
(0.8%)
30 Apr 2010
7,352,691
2.6%
(213,069)
(2.9%)
(154,948)
(2.1%)
(230,699)
(3.1%)
30 Apr 2011
8,422,455
14.5%
163,921
1.9%
224,829
2.7%
132,924
1.6%
30 Apr 2012
8,388,061
(0.4%)
(328,494)
(3.9%)
(288,317)
(3.4%)
(358,577)
(4.3%)
31 Dec 2012
5,486,640
-
993,895
18.1%
1,011,616
18.4%
885,960
16.1%
31 Dec 2013
12,073,487
-
1,677,123
13.9%
1,709,761
14.2%
1,646,498
13.6%
31 Dec 2014
13,388,661
10.9%
2,054,481
15.3%
2,087,407
15.6%
13,454,465
100.5%
31 Dec 2015
0
(100%)
0
-
0
-
0
-
31 Dec 2016
-
-
0
-
0
-
588,000
-
31 Dec 2017
-
-
0
-
0
-
593,512
-
31 Dec 2018
31 Dec 2019
31 Dec 2020

Unlock the recent years of financials and more for Nexus Oncology Ltd..

Request a demo to see more.

Deals

Deals Type
Private Debt
Deal Status Target (s) Deal Date Investor(s) Seller(s) Deal size (Mn) Enterprise value (Mn) Post-money valuation (Mn) EBITDA multiple (x) Revenue multiple (x) Lead partner (s)
Completed Nexus Oncology Ltd. 31 Jan 2012
Displaying 1-1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo